Indaptus Therapeutics, Inc. (INDP)
2.86
-0.27
(-8.63%)
USD |
NASDAQ |
Nov 20, 16:00
2.86
0.00 (0.00%)
After-Hours: 20:00
Indaptus Therapeutics Gross Profit (TTM) : 0.00 for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.00 |
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | -0.0007M |
| September 30, 2024 | -0.0011M |
| June 30, 2024 | -0.0014M |
| March 31, 2024 | -0.0017M |
| December 31, 2023 | -0.0013M |
| September 30, 2023 | -0.0013M |
| June 30, 2023 | -0.0014M |
| March 31, 2023 | -0.0016M |
| December 31, 2022 | -0.0018M |
| September 30, 2022 | -0.002M |
| June 30, 2022 | -0.0016M |
| March 31, 2022 | -0.0013M |
| December 31, 2021 | -0.001M |
| September 30, 2021 | -0.0006M |
| June 30, 2021 | -0.0006M |
| March 31, 2021 | -0.3054M |
| December 31, 2020 | -0.6112M |
| September 30, 2020 | -0.822M |
| Date | Value |
|---|---|
| June 30, 2020 | -1.034M |
| March 31, 2020 | -0.942M |
| December 31, 2019 | -0.854M |
| September 30, 2019 | -0.863M |
| June 30, 2019 | -0.874M |
| March 31, 2019 | -0.871M |
| December 31, 2018 | -0.859M |
| September 30, 2018 | -0.855M |
| June 30, 2018 | -0.845M |
| March 31, 2018 | -0.635M |
| December 31, 2017 | -0.429M |
| September 30, 2017 | -0.213M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | -0.3324M |
| June 30, 2016 | -0.4946M |
| March 31, 2016 | -0.6212M |
| December 31, 2015 | -0.7466M |
| September 30, 2015 | -0.5461M |
| June 30, 2015 | -0.5295M |
| March 31, 2015 | -0.5582M |
| December 31, 2014 | -0.5864M |
| September 30, 2014 | -0.6086M |
| June 30, 2014 | -0.6151M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Cypherpunk Technologies, Inc. | 7.783M |
| Capricor Therapeutics, Inc. | -2.559M |
| Ocugen, Inc. | 3.248M |
| Cue Biopharma, Inc. | 35.43M |
| Yarrow Bioscience, Inc. | 0.296M |